Evidence map›Paper›PMID 34551208›Full record

SynthesisESC heart failure2021

Right ventricular dysfunction and tricuspid regurgitation in functional mitral regurgitation.

Vien T Truong, Tam N M Ngo, Jan Mazur, Hoai T M Nguyen, Thuy T M Pham, Cassady Palmer, Khanh N P Pham, Hoang T Phan, Kwan S Lee, Marwin Bannehr and 3 more

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in ESC heart failure, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 11 institutions in 5 countries.

Vien T TruongThe Christ Hospital Health Network, 2139 Auburn Ave, Cincinnati, OH, 45219, USA.
Tam N M NgoThe Christ Hospital Health Network, 2139 Auburn Ave, Cincinnati, OH, 45219, USA.
Jan MazurThe Ohio State University, Columbus, OH, USA.
Hoai T M NguyenPham Ngoc Thach University of Medicine, Ho Chi Minh city, Vietnam.
Thuy T M PhamHeart Center, Tam Anh General Hospital, Ho Chi Minh City, Vietnam.
Cassady PalmerThe Christ Hospital Health Network, 2139 Auburn Ave, Cincinnati, OH, 45219, USA.
Khanh N P Pham115 People's Hospital, Ho Chi Minh City, Vietnam.
Hoang T PhanPham Ngoc Thach University of Medicine, Ho Chi Minh city, Vietnam.
Kwan S LeeSarver Heart Center, Department of Medicine, University of Arizona College of Medicine, Tucson, AZ, USA.
Marwin BannehrHeart Center Brandenburg in Bernau/Berlin, Department of Cardiology & Brandenburg, Medical School Theodor Fontane, Neuruppin, Germany.
Christian ButterHeart Center Brandenburg in Bernau/Berlin, Department of Cardiology & Brandenburg, Medical School Theodor Fontane, Neuruppin, Germany.
Takayuki GyotenCardiac Surgery, SanaHerzzentrum Cottbus, Cottbus, Germany.
Eugene S ChungThe Christ Hospital Health Network, 2139 Auburn Ave, Cincinnati, OH, 45219, USA.
Health Net · USMedizinische Hochschule Brandenburg Theodor Fontane · DEBühler (United Kingdom) · GBCarl-Thiem-Klinikum Cottbus · DEChrist Hospital · USKhanh Hoa General Hospital · VNPham Ngoc Thach Hospital · VNPham Ngoc Thach University of Medicine · VNThe Ohio State University · USUniversity of Arizona · USUniversity of Tasmania · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThe objective of this study was to investigate the prognostic importance of right ventricular dysfunction (RVD) and tricuspid regurgitation (TR) in patients with moderate-severe functional mitral regurgitation (FMR) receiving MitraClip procedure. RVD and TR grade are associated with cardiovascular mortality in the general population and other cardiovascular diseases. However, there are limited data from observational studies on the prognostic significance of RVD and TR in FMR receiving MitraClip procedure. METHODS AND

resultsA systemic review and meta-analysis were performed using MEDLINE, Scopus, and Embase to assess the prognostic value of RVD and TR grade for mortality in patients with functional mitral regurgitation (FMR) receiving MitraClip procedure. Hazard ratios were extracted from multivariate models reporting on the association of RVD and TR with mortality and described as pooled estimates with 95% confidence intervals. A total of eight non-randomized studies met the inclusion criteria with seven studies having at least 12 months follow-up with a mean follow-up of 20.9 months. Among the aforementioned studies, a total of 1112 patients (71.5% being male) were eligible for being included in our meta-analysis with an overall mortality rate of 28.4% (n = 316). Of the enrolled patients, RVD was present in 46.1% and moderate-severe TR in 29.2%. RVD was significantly associated with mortality compared to normal RV function (HR, 1.79, 95% CI, 1.39-2.31, P < 0.001, I

conclusionsThis meta-analysis demonstrates the prognostic importance of RVD and TR grade in predicting all-cause mortality in patients with significant FMR. RV function and TR parameters may therefore be useful in the risk stratification of patients with significant FMR undergoing MitraClip procedure.

Indexed as

Mitral Valve InsufficiencyTricuspid Valve InsufficiencyVentricular Dysfunction, RightFemaleHumansMaleRetrospective StudiesTreatment OutcomeFunctional mitral regurgitationMeta-analysisMitraClip procedureMortalityRight ventricular dysfunctionTricuspid regurgitation

Identifiers

PMID34551208
PMCPMC8712790
OpenAlexW3199663790

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.